|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
After former FDA Commissioner Marty Makary resigned last week, a high-level shakeup of the key regulator led to a slew of exits and new roles. Acting CDER director Tracy Beth Høeg said she was fired, acting CBER chief Katherine Szarama and Chief of Staff Jim Traficant were replaced, though they're staying at the agency, and reports said that Chief AI Officer Jeremy Walsh resigned. The search for a permanent commissioner replacement is now on, which the Trump administration is reportedly hoping to conduct quickly. |
|
|
|
Max Bayer |
Pharma Reporter, Endpoints News
|
|
|
|
 |
|
Tracy Beth Høeg (Mike Stewart/AP Images) |
|
|
|
by Max Bayer, Drew Armstrong
|
The leader of the FDA's drug division, Tracy Beth Høeg, is expected to depart, as part of a broad shakeup at the top of the... | |
|
|
|
|
|
|
by Drew Armstrong
|
An analysis launched by former FDA leaders to look into claims of pediatric deaths related to Covid-19 vaccines was published by a Republican lawmaker, months... | |
|
|
|
|
|
|
by Nicole DeFeudis
|
The Supreme Court will continue to allow the abortion pill mifepristone to be distributed by mail, at least for now. The Thursday rulingmaintains mifepristone's... | |
|
|
|
|
|
|
by Andrew Dunn
|
The FDA wants it off the market. European regulators are investigating data-integrity concerns. And now, a pharma company selling the drug in Japan is warning... | |
|
|
|
 |
|
President Donald Trump with Mark Cuban and CMS Administrator Mehmet Oz on May 18, 2026 (Julia Demaree Nikhinson/AP Images) |
|
|
|
by Max Bayer
|
The Trump administration is significantly building the portfolio of drugs available through its direct-to-consumer platform TrumpRx, adding more than 600 generic medicines. President Donald Trump... | |
|
|
|
|
|
|
by Drew Armstrong
|
Marty Makary resigned as FDA commissioner on Tuesdayafter a turbulent tenure at the head of the agency. Makary was scheduled to sit down with... | |
|
|
|
|
|
